Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Serica's Rhum starts production; XLMedia buys in US

Thu, 02nd Sep 2021 14:43

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Serica Energy PLC - London-based oil & gas company - Starts production from the Rhum R3 well in UK North Sea. In the last seven days, gross Rhum production has averaged over 190mmcsf per day of gas and 1,400bbl/d of condensate. This equates to an average gross production in excess of 34,000 boe per day for the Rhum field. This compares to a maximum rate of 26,000 boe per day immediately prior to the commencement of R3 production. "Further work will continue in the coming weeks to optimise and stabilise production and if necessary," company says. Serica has a 50% working interest in the Rhum field.

----------

88 Energy Ltd - Alaska-focused oil exploration and appraisal company - Raises AUD24.0 million, about GBP12.7 million, through issue of 855.9 million shares at about 1.49 pence each. Trading at 1.74p in London on Thursday afternoon. Net proceeds to be used to strengthen balance sheet and finance drilling and logging of the Merlin-2 appraisal well. Chief Executive Ashley Gilbert says: "We will continue to evaluate potential strategic partners for the Peregrine Project, in which we maintain a 100% working interest. However, ensuring our ability to fully fund Merlin-2 via this placing delivers us excellent commercial leverage and optionality with respect to these discussions."

----------

Dev Clever Holdings PLC - Tamworth, England-based software developer for immersive career guidance and consumer engagement experiences - Says first phase of "tactical partnership" with Dubai-based Aldebaron DMCC has now been agreed and signed. Under the terms of the partnership, the National Careers Challenge will be launched in the UK on September 30. Concurrently, plans for an Indian NCC are anticipated to be finalised in the fourth quarter for full scale launch during the first half of 2022. "Aldebaron has made specific revenue commitments to Dev Clever across the collaboration period for a minimum amount of USD50 million with the first phase being USD5 million to be accounted for in this financial year ending October 31 2021 and subsequently USD10 million in FY22, USD15 million in FY23, and USD20 million FY24," company adds.

----------

Fintel PLC - Huddersfield-based business services provider to financial advisers - Creates "distribution as a service" unit, signs up Schroders, Just, Guardian, BMO and 91 Asset Management for the new offering. "The new subscription service is another Fintel first and includes market analysis via Fintel's proprietary insights, product design, compliance consultancy and targeted distribution services via Fintel's data sets and events programme, the largest of its kind in the UK," company explains. Chief Executive Matt Timmins adds: "Fintel operates as the connecting force between product providers, intermediaries and consumers, with a mission to simplify and improve how the market operates through technology, people and insights. The launch of our managed distribution service reflects our commitment to simplify complexity, think bigger and deliver future focused solutions to inspire better outcomes in retail financial services."

----------

RBG Holdings PLC - London-based law firm - Integration of Memery Crystal is "progressing well". To combine two law firms, Rosenblatt Ltd and Memery Crystal Ltd into a new legal services corporate entity to be called RBG Legal Services. "While we will retain both brands, we see opportunities to deliver considerable value for shareholders by integrating the two firms, leveraging each businesses skills and resources to benefit the other. I will be directly overseeing the integration over the next few months to ensure we maximise these opportunities," Chief Executive Nicola Foulston says. Foulston will also become interim CEO of RBGLS for the next six months to directly oversee the commercial and cultural integration, company says.

----------

IronRidge Resources Ltd - Australia-based minerals exploration company - Reports additional broad and high-grade lithium pegmatite drill intersections at new targets adjacent to the Ewoyaa lithium project, where company has defined a JORC compliant mineral resource estimate of 14.5 million tonnes at 1.31% lithium oxide in the inferred and indicated category, including 4.5 million tonnes at 1.39% lithium oxide in the indicated category in Ghana, West Africa. Drilling results include 0.4% Li2O cut-off and maximum 4 metres of internal dilution. Chief Executive Vincent Mascolo says: "We are highly encouraged by the ongoing results received from new targets adjacent to Ewoyaa, which continue to confirm high grades in new exploration targets tested within the ELP area."

----------

Surface Transforms PLC - Liverpool-based maker of carbon‐ceramic automotive brake discs - Says its new strategy will increase 2023 sales capacity to GBP50 million per year from GBP35 million, with no new capital equipment cash requirement. Also says it has been awarded a new contract as a tier one supplier of a carbon ceramic brake disc to its existing mainstream customer described previously as OEM 5. Contract is worth EUR5 million spread over 5 years from 2024 to 2028. Chief Executive Kevin Johnson says: "The significance of this relatively small contract lies in it being the first example of the implementation of the multi-year 'carry over' agreement concluded with OEM 5 at the time of the initial contract award in July 2019. This envisaged further awards, of varying sizes, over several years. A further award in 2020 did not happen because of a Covid induced programme cancellation by the customer. It is good to be now back on track."

----------

Redx Pharma PLC - Cheshire-based cancer and fibrosis drug developer - Nets USD3 million milestone payment from Jazz Pharmaceuticals PLC, which was triggered as a result of the initiation of IND-enabling studies of JZP815, a preclinical Pan-RAF inhibitor, for the potential treatment of RAF driven tumours. Mutations leading to uncontrolled signalling in the RAS-RAF-MAPK pathway are seen in around one third of all cancers. Redx is entitled to up to USD203 million in development, regulatory and commercial milestone payments. Company also eligible for royalties based on any future net sales. The next milestone payment under the agreement is due on acceptance of an Investigational New Drug application by the US Food & Drug Administration.

----------

XLMedia PLC - London-based marketing firm operating in online gaming, personal finance and sports - Buys online publisher of US college football news Saturday Football Inc for USD23.0 million cash plus USD1.0 million in long term incentive shares. Company will pay USD11.0 million up front, plus USD12.0 million over next three years. In addition, the founders, who are remaining with the business, will receive USD1.0 million in long-term incentive shares. Founded in 2014, Saturday Football operates two college football media sites, saturdaydownsouth.com and saturdaytradition.com, which cover the Southeastern Conference and Big 10 college sports conferences.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Granted a permit to import CimetrA into India by the Indian Central Drugs Standard Control Organisation as a final step towards obtaining emergency use authorisation for the treatment of patients with Covid-19. Co-Founder & Managing Director Roby Zomer says: "We are pleased to have secured a license to import CimetrA as an Emergency Use Drug in India, and hope that we can secure approval swiftly to expand its availability to a much wider patient base. India has been acutely affected by the Covid-19 pandemic and we believe that CimetrA can make an important difference in treating the symptoms of Covid-19 and alleviate patient suffering. It is important that we have secured Medopharm, as the importer and the marketing authorisation holder of CimetrA given their vast experience of taking medicinal products through the process to full approval for sale."

----------

Advance Energy PLC - upstream oil and gas company - Operator of Buffalo-10 well, Carnarvon Petroleum, signs formal rig contract for a jack-up rig with Valaris. "The VALARIS JU-107 jack-up drilling rig is currently working in the Timor Sea, on the Montara field 300 kilometres southwest of the Buffalo field, and only a short tow away from the Buffalo field," company says. Adds: "The final well timing will be subject to securing the remaining drilling support services and equipment, and joint venture and regulatory approvals, all of which are well progressed." The Buffalo-10 well is designed to test the presence of a significant attic oil accumulation that remains after the original development was closed-in and convert the 2C certified resources.

----------

Carclo PLC - West Yorkshire-based plastic parts manufacturer - Makes "encouraging" start to financial 2022, which ends March 31, by maintaining the momentum built in the second half of the prior year. As a result, trading was ahead of management's expectations for the first four months of the period, with performance also ahead of the equivalent prior period. Carclo Technical Plastics unit performs "strongly" but notes availability and pricing of raw materials has been "difficult" in recent months. Aerospace unit sees early signs of market recovery as order intake exceeds sales for the first four months year on year.

----------

Wishbone Gold PLC - precious metals trading and exploration company with assets in Australia - Finds 7 geophysical targets varying in size up to 3.7 kilometres by 1.2 kilometres at Cottesloe project in the Patersons Range of Western Australia. Notes Cottesloe tenement E45/4543 term has been extended by the Western Australian government by 5 years to 2026. Chair Richard Poulden says: "This is exciting news to have the 5 year extension granted. Our examination of additional unpublished data has fully justified our optimism in Cottesloe. It is in a great location between the existing Nifty copper mine to the north and the Maroochydore copper project in the south, both with major copper resources." Sampling includes 5 metres at 102 grams per tonne gold from 14 metres.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Sep 2022 17:52

TRADING UPDATES: Strong interim results from Johnson Service, Eurocell

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Aug 2022 11:57

IN BRIEF: Graft Polymer wins first commercial order for GraftBio

Graft Polymer (UK) PLC - London-based company focused on the development and production of polymer modification, biological supplements, and nano-drug delivery systems - Wins first commercial purchase order for its GraftBio division. Order for 50,000 units of its anti-inflammatory supplement, ArtemiC Rescue from MGC Pharmaceuticals PLC. Order worth around USD1 million. Production to start immediately. Delivery expected over the next three months. Chief Executive Victor Volduev says he expects follow-on orders in the coming quarters.

Read more
17 Aug 2022 11:12

MGC shares rise on USD1 million order for ArtemiC

(Alliance News) - MGC Pharmaceuticals Ltd shares were lifted on Wednesday after it announced a USD1 million order for its neutraceutical, ArtemiC.

Read more
15 Aug 2022 17:31

IN BRIEF: MGC Pharma's CannEpil found safe for driving in study

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says clinical study results for its epilepsy treatment, CannEpil, are complete. The study found CannEpil to be safe for post-treatment driving activities. It used a driving simulator to test whether the drug caused somnolence, ie drowsiness, or impairs cognition. It was sponsored by Cannvalate Australia, and conducted by the Centre of Human Psychopharmacology at Swinburne University of Technology, under the Medical Cannabis Research Collaboration.

Read more
5 Aug 2022 14:58

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
29 Jul 2022 19:36

TRADING UPDATES: Walker Crips assets grow; Minoan interim loss narrows

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Jul 2022 20:08

TRADING UPDATES: Scottish American outperforms; Amte picks Dundee

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Jul 2022 21:53

IN BRIEF: MGC Pharmaceuticals quarterly sales "strong"

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says "strong" quarterly sales continue, notes AUD1.6 million, about GBP923,000, in cash receipts during three month period to June 30. In 12-month period, records AUD6.1 million in cash receipts.

Read more
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
8 Jul 2022 14:19

IN BRIEF: MGC Pharmaceuticals wins approval for Covid study, shares up

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Receives approval from South African Health Products Regulatory Authority for a Phase 2b dose finding study of its nanoparticle formulation CimetrA on patients diagnosed with Covid-19.

Read more
6 Jul 2022 20:08

IN BRIEF: MGC Pharmaceuticals launches medical data app ZAM

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says it is set to launch a real-time data collection application, ZAM, for use across the pharmaceutical and health care sectors, in collaboration with software development company, Caba Tech. The app will be available during the third quarter and will enable patients to log their medical history and monitor their medication use. ZAM, through the collection the patient data, will also provide users with a more complete understanding of their health and treatments, it says.

Read more
27 Jun 2022 20:27

IN BRIEF: MGC's CimetrA shows promise beyond Covid applications

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says preliminary results from pre-clinical in vitro study of CimetrA show it could have "wide-ranging application" as anti-inflammatory treatment. This is through the treatment's modulation of the production of pro-inflammatory cytokines. The study was undertaken by Israeli contract research organisation, Science in Action. Results support previous findings from a 2020 study into Covid-19, which showed CimetrA modulates the body's production of cytokines, which can lead to a cytokine storm, a type of severe immune reaction. New results support the potential of CimetrA to have a wider-ranging application as anti-inflammatory treatment, beyond the treatment of Covid-19 symptoms.

Read more
24 Jun 2022 10:13

IN BRIEF: MGC Pharma moves ahead with Covid-19 treatment in US

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Progresses plans to begin US clinical trial for its Covid-19 treatment CimetrA, as MGC and AMC Holdings Inc executives meet with department heads from the University of South Florida. Parties also discuss regulatory approvals for phytocannabinoid medicines CogniCann and CannEpil in the US for early patient access schemes. Says US market access and distribution agreement has been signed with minimum orders of USD24 million over three years, including CimetrA.

Read more
16 Jun 2022 13:43

IN BRIEF: MGC Pharmaceuticals completes research study on brain cancer

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes an in-vitro preclinical research study with the National Institute of Biology into the use of cannabinoids to treat brain cancer. The company says the study, undertaken on 30 biopsy samples from 18 patients over a period of three years, sought to determine the optimal formulation for the treatment of Glioblastoma, a form of brain cancer. The study showed that MGC Pharma's proprietary formulations were cytotoxic to Glioblastoma tumour and stem cells, reducing the cells' viability and inducing caspase-dependent cell apoptosis, or cell death.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.